BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30818762)

  • 1. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
    Skucha A; Ebner J; Grebien F
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
    Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
    Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia.
    Bu J; Chen A; Yan X; He F; Dong Y; Zhou Y; He J; Zhan D; Lin P; Hayashi Y; Sun Y; Zhang Y; Xiao Z; Grimes HL; Wang QF; Huang G
    Leukemia; 2018 Apr; 32(4):890-899. PubMed ID: 29249820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETD2-dependent H3K36me3 plays a critical role in epigenetic regulation of the HPV31 life cycle.
    Gautam D; Johnson BA; Mac M; Moody CA
    PLoS Pathog; 2018 Oct; 14(10):e1007367. PubMed ID: 30312361
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mar BG; Chu SH; Kahn JD; Krivtsov AV; Koche R; Castellano CA; Kotlier JL; Zon RL; McConkey ME; Chabon J; Chappell R; Grauman PV; Hsieh JJ; Armstrong SA; Ebert BL
    Blood; 2017 Dec; 130(24):2631-2641. PubMed ID: 29018079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.
    Hacker KE; Fahey CC; Shinsky SA; Chiang YJ; DiFiore JV; Jha DK; Vo AH; Shavit JA; Davis IJ; Strahl BD; Rathmell WK
    J Biol Chem; 2016 Sep; 291(40):21283-21295. PubMed ID: 27528607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SETD2, an epigenetic tumor suppressor: a focused review on GI tumor.
    Hu M; Hu M; Zhang Q; Lai J; Liu X
    Front Biosci (Landmark Ed); 2020 Jan; 25(4):781-797. PubMed ID: 31585917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway.
    Mac M; DeVico BM; Raspanti SM; Moody CA
    J Virol; 2023 May; 97(5):e0020123. PubMed ID: 37154769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Chromatin-Cytoskeleton Link in Cancer.
    Giaccia AJ
    Mol Cancer Res; 2016 Dec; 14(12):1173-1175. PubMed ID: 27528705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer.
    Kumari S; Muthusamy S
    Eur J Cancer Prev; 2020 Nov; 29(6):556-564. PubMed ID: 33021769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.
    Carvalho S; Vítor AC; Sridhara SC; Martins FB; Raposo AC; Desterro JM; Ferreira J; de Almeida SF
    Elife; 2014 May; 3():e02482. PubMed ID: 24843002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone methyltransferase SETD2 coordinates FACT recruitment with nucleosome dynamics during transcription.
    Carvalho S; Raposo AC; Martins FB; Grosso AR; Sridhara SC; Rino J; Carmo-Fonseca M; de Almeida SF
    Nucleic Acids Res; 2013 Mar; 41(5):2881-93. PubMed ID: 23325844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.
    Fahey CC; Davis IJ
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of SETD2 stability is important for the fidelity of H3K36me3 deposition.
    Bhattacharya S; Workman JL
    Epigenetics Chromatin; 2020 Oct; 13(1):40. PubMed ID: 33023640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shaping the cellular landscape with Set2/SETD2 methylation.
    McDaniel SL; Strahl BD
    Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers.
    Chen R; Zhao WQ; Fang C; Yang X; Ji M
    J Cancer; 2020; 11(11):3349-3356. PubMed ID: 32231741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between H3K36me3, methyltransferase SETD2, and mismatch recognition protein MutSα facilitates processing of oxidative DNA damage in human cells.
    Guo S; Fang J; Xu W; Ortega J; Liu CY; Gu L; Chang Z; Li GM
    J Biol Chem; 2022 Jul; 298(7):102102. PubMed ID: 35667440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.
    Zhou Y; Zheng X; Xu B; Deng H; Chen L; Jiang J
    Aging (Albany NY); 2020 Nov; 12(24):25189-25206. PubMed ID: 33223508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.